MICHAEL DENT - 01 Dec 2023 Form 4 Insider Report for HealthLynked Corp (HLYK)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Michael Dent
Issuer symbol
HLYK
Transactions as of
01 Dec 2023
Transactions value $
$666,500
Form type
4
Filing time
04 Apr 2024, 16:37:52 UTC
Previous filing
15 Sep 2023
Next filing
24 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HLYK Warrant Other $0 +1,500,000 $0 1,500,000 01 Dec 2023 Common stock 1,500,000 $0.06 Held by Trust F1, F2
transaction HLYK 12% Convertible Notes Other $150,000 $150,000 27 Mar 2024 Common stock 2,617,801 $0.0573 Held by Trust F2, F3, F4
transaction HLYK 12% Convertible Notes Other $350,000 $350,000 27 Mar 2024 Common stock 6,108,202 $0.0573 Held by Trust F2, F3, F4
transaction HLYK 12% Convertible Notes Other $166,500 $166,500 27 Mar 2024 Common stock 2,905,759 $0.0573 Held by Trust F2, F3, F4, F5
transaction HLYK Warrant Other $0 +6,660,000 $0 6,660,000 29 Mar 2024 Common stock 6,660,000 $0.06 Held by Trust F2, F6
transaction HLYK Employee stock option Award $0 +1,600,000 $0 1,600,000 29 Mar 2024 Common stock 1,600,000 $0.0569 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person's trust received warrants to purchase shares of Issuer's common stock as warrant coverage in connection with the purchase of an unsecured promissory note with a face value of $150,000 from the Issuer on the transaction date.
F2 Held beneficially by the Mary S. Dent Gifting Trust dated January 31, 2006. The reporting person is the trustee of such trust.
F3 The reporting person's trust purchased this convertible note from the Issuer.
F4 Excludes shares issuable at the election of the reporting person upon conversion of accrued interest into shares of common stock.
F5 The reporting person's trust was issued a 12% Convertible Note in the principal amount of $166,500 in exchange for an unsecured promissory note in the principal amount of $166,500 previously issued to the reporting person's trust.
F6 The reporting person's trust received the warrants to purchase shares of Issuer's common stock as warrant coverage in connection with the issuance of the three convertible notes reported on this Table II.
F7 The option vesting schedule is: 900,000 shares upon grant, 150,000 shares on July 31, 2024, 200,000 shares on March 29, 2025, 150,000 shares on July 31, 2025 and 200,000 shares on March 29, 2026.